Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.
The global market for Human Chorionic Gonadotropin (HCG) was estimated to be worth US$ 745.2 million in 2023 and is forecast to a readjusted size of US$ 1173.2 million by 2030 with a CAGR of 6.6% during the forecast period 2024-2030
The growth of the human chorionic gonadotropin (HCG) market is attributed to the increasing prevalence of infertility and hypogonadism, changing lifestyles, and increased awareness regarding infertility treatment. Hypogonadism, for example, is characterized by low serum testosterone concentration, which is followed by a number of clinical features such as erectile dysfunction (ED), poor morning erections, low libido, memory loss, physical decline in strength and health, difficulty concentrating, and depression.According to the study published by BMC Endocrine Disorders in July 2021, erectile dysfunction was found to be prevalent in 72.2% of people globally in 2021. Furthermore, according to the CDC update in March 2022, about 1 in 5 (22%) couples in which the woman is 30-39 have problems conceiving their first child, compared to about 1 in 8 (13%) couples in which the woman is younger than 30. Age-related fertility loss is mostly caused by deteriorating egg quality. Older women also have fewer remaining eggs and are more likely to have health issues that can affect fertility. Aging also increases a woman’s chances of miscarriage and of having a child with a genetic abnormality. Therefore, the high burden of infertility is also raising the demand for effective treatments such as human chorionic gonadotropin (HCG) hormones, which is fueling the market's growth.
A 2024 latest Report by QYResearch offers on -“Human Chorionic Gonadotropin (HCG) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030” provides an extensive examination of Human Chorionic Gonadotropin (HCG) market attributes, size assessments, and growth projections through segmentation, regional analyses, and country-specific insights, alongside a scrutiny of the competitive landscape, player market shares, and essential business strategies.
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the future. The information presented is based on historical milestones and current trends, providing a detailed analysis of the production volume for each type from 2017 to 2030, as well as the production volume by region during the same period.
This inquiry delivers a thorough perspective with valuable insights, accentuating noteworthy outcomes in the industry. These insights empower corporate leaders to formulate improved business strategies and make more astute decisions, ultimately enhancing profitability. Furthermore, the study assists private or venture participants in gaining a deep understanding of businesses, enabling them to make well-informed choices.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/2334554/human-chorionic-gonadotropin--hcg
The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.
The Human Chorionic Gonadotropin (HCG) market is segmented as below:
By Company
EMD Serono, Inc
Ferring B.V
Merck & Co., Inc
Bristol Myers Squibb Company
Fresenius Kabi AG
Scripps Laboratories
Leebio
Kamiya Biomedical Company
Sanzyme
Cigna
LUPIN
Sun Pharmaceutical Industries Ltd
Serum Institute of India Pvt. Ltd
VHB Medi Sciences Limited
Zydus Lifesciences Ltd
Corona Remedies Pvt. Ltd.
Segment by Type
Natural Source Extraction
Recombinant DNA Technology
Segment by Application
Female Infertility Treatment
Oligospermic Treatment
Cryptorchidism Treatment
Others
The Human Chorionic Gonadotropin (HCG) report is compiled with a thorough and dynamic research methodology.
The report offers a complete picture of the competitive scenario of Human Chorionic Gonadotropin (HCG) market.
It comprises vast amount of information about the latest technology and product developments in the Human Chorionic Gonadotropin (HCG) industry.
The extensive range of analyses associates with the impact of these improvements on the future of Human Chorionic Gonadotropin (HCG) industry growth.
The Human Chorionic Gonadotropin (HCG) report has combined the required essential historical data and analysis in the comprehensive research report.
The insights in the Human Chorionic Gonadotropin (HCG) report can be easily understood and contains a graphical representation of the figures in the form of bar graphs, statistics, and pie charts, etc.
Each chapter of the report provides detailed information for readers to further understand the Human Chorionic Gonadotropin (HCG) market:
Chapter 1- Executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2- Detailed analysis of Human Chorionic Gonadotropin (HCG) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 3- Sales, revenue of Human Chorionic Gonadotropin (HCG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 4- Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 5,6,7,8,9 - North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 10- Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 11- Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 12 - Analysis of sales channel, distributors and customers.
Chapter 13- Research Findings and Conclusion.
Table of Contents
1 Human Chorionic Gonadotropin (HCG) Market Overview
1.1 Human Chorionic Gonadotropin (HCG) Product Overview
1.2 Human Chorionic Gonadotropin (HCG) Market by Type
1.3 Global Human Chorionic Gonadotropin (HCG) Market Size by Type
1.3.1 Global Human Chorionic Gonadotropin (HCG) Market Size Overview by Type (2019-2030)
1.3.2 Global Human Chorionic Gonadotropin (HCG) Historic Market Size Review by Type (2019-2024)
1.3.3 Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size by Type (2025-2030)
1.4 Key Regions Market Size by Type
1.4.1 North America Human Chorionic Gonadotropin (HCG) Sales Breakdown by Type (2019-2024)
1.4.2 Europe Human Chorionic Gonadotropin (HCG) Sales Breakdown by Type (2019-2024)
1.4.3 Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales Breakdown by Type (2019-2024)
1.4.4 Latin America Human Chorionic Gonadotropin (HCG) Sales Breakdown by Type (2019-2024)
1.4.5 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Breakdown by Type (2019-2024)
2 Human Chorionic Gonadotropin (HCG) Market Competition by Company
3 Human Chorionic Gonadotropin (HCG) Status and Outlook by Region
3.1 Global Human Chorionic Gonadotropin (HCG) Market Size and CAGR by Region: 2019 VS 2023 VS 2030
3.2 Global Human Chorionic Gonadotropin (HCG) Historic Market Size by Region
3.2.1 Global Human Chorionic Gonadotropin (HCG) Sales in Volume by Region (2019-2024)
3.2.2 Global Human Chorionic Gonadotropin (HCG) Sales in Value by Region (2019-2024)
3.2.3 Global Human Chorionic Gonadotropin (HCG) Sales (Volume & Value), Price and Gross Margin (2019-2024)
3.3 Global Human Chorionic Gonadotropin (HCG) Forecasted Market Size by Region
3.3.1 Global Human Chorionic Gonadotropin (HCG) Sales in Volume by Region (2025-2030)
3.3.2 Global Human Chorionic Gonadotropin (HCG) Sales in Value by Region (2025-2030)
3.3.3 Global Human Chorionic Gonadotropin (HCG) Sales (Volume & Value), Price and Gross Margin (2025-2030)
...
Our Service：
- Express Delivery Report Service
- More than 16 years of vast experience
- Establish offices in 6 countries
- Operation for 24 * 7 & 365 days
- Owns large database
- In-depth and comprehensive analysis
- Professional and timely after-sales service
To contact us and get this report: https://www.qyresearch.com/contact-us
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. QYResearch focus on key industry players and analysis of production and sales operations. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. We have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world. QYResearch has the tools and expertise to help you succeed. We can help you achieve your business goals.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp